{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:33:53Z","timestamp":1767598433556,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2021J01431"],"award-info":[{"award-number":["2021J01431"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2023GGA056"],"award-info":[{"award-number":["2023GGA056"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Startup Fund for Scientific Research, Fujian Medical University, China","award":["2021QH1141"],"award-info":[{"award-number":["2021QH1141"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"DOI":"10.1186\/s12893-024-02550-9","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T06:02:48Z","timestamp":1725948168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Oncological outcomes of minimally invasive surgery in non-endometrioid endometrial Cancer patients with varying prognostic risks: a retrospective cohort study based on the ESGO\/ESTRO\/ESP 2020 guidelines"],"prefix":"10.1186","volume":"24","author":[{"given":"Bin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenju","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuibo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanzhen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,10]]},"reference":[{"key":"2550_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2550_CR2","doi-asserted-by":"publisher","first-page":"100581","DOI":"10.1016\/j.ctarc.2022.100581","volume":"32","author":"G Nogueira-Costa","year":"2022","unstructured":"Nogueira-Costa G, Eiriz I, Braga S. Non-endometrioid endometrial cancer: analysis of different adjuvant treatment modalities. Cancer Treat Res Commun. 2022;32:100581.","journal-title":"Cancer Treat Res Commun"},{"key":"2550_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/ijgc-2022-004073","volume":"33","author":"G Bogani","year":"2023","unstructured":"Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Caruso G, et al. Endometrial carcinosarcoma. Int J Gynecol Cancer. 2023;33:147\u201374.","journal-title":"Int J Gynecol Cancer"},{"key":"2550_CR4","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ygyno.2004.08.019","volume":"95","author":"WT Creasman","year":"2004","unstructured":"Creasman WT, Kohler MF, Odicino F, Maisonneuve P, Boyle P. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol. 2004;95:593\u20136.","journal-title":"Gynecol Oncol"},{"key":"2550_CR5","first-page":"579","volume":"33","author":"T Goto","year":"2012","unstructured":"Goto T, Takano M, Aoyama T, Miyamoto M, Watanabe A, Kato M, et al. Prognosis of high-grade endometrial cancer: a comparison of serous-type and clear cell type to grade 3 endometrioid-type. Eur J Gynaecol Oncol. 2012;33:579\u201383.","journal-title":"Eur J Gynaecol Oncol"},{"key":"2550_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ygyno.2013.03.011","volume":"129","author":"TA Ayeni","year":"2013","unstructured":"Ayeni TA, Bakkum-Gamez JN, Mariani A, McGree ME, Weaver AL, Haddock MG, et al. Comparative outcomes assessment of uterine grade 3 endometrioid, serous, and clear cell carcinomas. Gynecol Oncol. 2013;129:478\u201385.","journal-title":"Gynecol Oncol"},{"key":"2550_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","volume":"21","author":"N Abu-Rustum","year":"2023","unstructured":"Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, et al. Uterine neoplasms, Version 1.2023, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw. 2023;21:181\u2013209.","journal-title":"J Natl Compr Canc Netw"},{"key":"2550_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejca.2016.07.001","volume":"65","author":"M Koskas","year":"2016","unstructured":"Koskas M, Jozwiak M, Fournier M, Vergote I, Trum H, Lok C, et al. Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer. Eur J Cancer. 2016;65:185\u201391.","journal-title":"Eur J Cancer"},{"key":"2550_CR9","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/ijgc-2020-001573","volume":"30","author":"S Pedra Nobre","year":"2020","unstructured":"Pedra Nobre S, Mueller JJ, Gardner GJ, Long Roche K, Brown CL, Soslow RA, et al. Comparison of minimally invasive versus open surgery in the treatment of endometrial carcinosarcoma. Int J Gynecol Cancer. 2020;30:1162\u20138.","journal-title":"Int J Gynecol Cancer"},{"key":"2550_CR10","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.asjsur.2021.09.023","volume":"45","author":"JH Ahn","year":"2022","unstructured":"Ahn JH, Park DC, Yoon JH, Lee SJ, Cha J, Yoo JG, et al. Oncologic safety of minimally invasive surgery in non-endometrioid endometrial cancer. Asian J Surg. 2022;45:1253\u20138.","journal-title":"Asian J Surg"},{"key":"2550_CR11","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1136\/ijgc-2021-003110","volume":"31","author":"M Daix","year":"2021","unstructured":"Daix M, Gladieff L, Martinez A, Ferron G, Angeles MA. Pocket memo based on the ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma: definition of prognostic risk groups. Int J Gynecol Cancer. 2021;31:1615\u20136.","journal-title":"Int J Gynecol Cancer"},{"key":"2550_CR12","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1001\/jama.2017.2068","volume":"317","author":"M Janda","year":"2017","unstructured":"Janda M, Gebski V, Davies LC, Forder P, Brand A, Hogg R, et al. Effect of total laparoscopic hysterectomy vs total abdominal hysterectomy on Disease-Free Survival among Women with Stage I endometrial Cancer: a Randomized Clinical Trial. JAMA. 2017;317:1224\u201333.","journal-title":"JAMA"},{"key":"2550_CR13","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1186\/s12885-021-08289-3","volume":"21","author":"C Borgfeldt","year":"2021","unstructured":"Borgfeldt C, Holmberg E, Marcickiewicz J, St\u00e5lberg K, Tholander B, Lundqvist E, et al. Survival in endometrial cancer in relation to minimally invasive surgery or open surgery - a Swedish Gynecologic Cancer Group (SweGCG) study. BMC Cancer. 2021;21:658.","journal-title":"BMC Cancer"},{"key":"2550_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.suronc.2020.02.015","volume":"34","author":"D Nasioudis","year":"2020","unstructured":"Nasioudis D, Heyward QD, Haggerty AF, Giuntoli Ii RL, Burger RA, Morgan MA, et al. Surgical and oncologic outcomes of minimally invasive surgery for stage I high-grade endometrial cancer. Surg Oncol. 2020;34:7\u201312.","journal-title":"Surg Oncol"},{"key":"2550_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12905-021-01364-8","volume":"21","author":"Y Kotani","year":"2021","unstructured":"Kotani Y, Murakami K, Fujishima R, Kanto A, Takaya H, Shimaoka M, et al. Research Article Quality of life after laparoscopic hysterectomy versus abdominal hysterectomy. BMC Womens Health. 2021;21:219.","journal-title":"BMC Womens Health"},{"key":"2550_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1470-2045(10)70143-1","volume":"11","author":"MJ Mourits","year":"2010","unstructured":"Mourits MJ, Bijen CB, Arts HJ, ter Brugge HG, van der Sijde R, Paulsen L, et al. Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial. Lancet Oncol. 2010;11:763\u201371.","journal-title":"Lancet Oncol"},{"key":"2550_CR17","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","volume":"379","author":"PT Ramirez","year":"2018","unstructured":"Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, et al. Minimally invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med. 2018;379:1895\u2013904.","journal-title":"N Engl J Med"},{"key":"2550_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08941939.2022.2126565","volume":"36","author":"B Liu","year":"2023","unstructured":"Liu B, Lin J, Liu W, Chen W, Lin W, Chen W. Recurrence and Survival Rates of patients who Undergo minimally invasive surgery for endometrial carcinoma with different prognostic risk groups. J Invest Surg. 2023;36:1\u201310.","journal-title":"J Invest Surg"},{"key":"2550_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejogrb.2021.11.012","volume":"268","author":"T Perri","year":"2022","unstructured":"Perri T, Levin G, Helpman L, Eitan R, Vaknin Z, Lavie O, et al. Minimally invasive approach in endometrial cancer with lower uterine segment involvement in stage\u2009\u2265\u2009II: a retrospective study. Eur J Obstet Gynecol Reprod Biol. 2022;268:43\u20137.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2550_CR20","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.7150\/ijms.52293","volume":"18","author":"SI Kim","year":"2021","unstructured":"Kim SI, Park DC, Lee SJ, Yoo JG, Song MJ, Kim CJ, et al. Minimally invasive surgery for patients with advanced stage endometrial cancer. Int J Med Sci. 2021;18:1153\u20138.","journal-title":"Int J Med Sci"},{"key":"2550_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ygyno.2021.04.029","volume":"162","author":"G Bogani","year":"2021","unstructured":"Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Enomoto T, et al. Uterine serous carcinoma. Gynecol Oncol. 2021;162:226\u201334.","journal-title":"Gynecol Oncol"},{"key":"2550_CR22","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.ygyno.2022.01.012","volume":"164","author":"G Bogani","year":"2022","unstructured":"Bogani G, Ray-Coquard I, Concin N, Ngoi NYL, Morice P, Enomoto T, et al. Clear cell carcinoma of the endometrium. Gynecol Oncol. 2022;164:658\u201366.","journal-title":"Gynecol Oncol"},{"key":"2550_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/AOG.0000000000004995","volume":"141","author":"G Dinoi","year":"2023","unstructured":"Dinoi G, Ghoniem K, Murad MH, Segarra-Vidal B, Zanfagnin V, Coronado PJ, et al. Minimally invasive compared with open surgery in high-risk endometrial Cancer: a systematic review and Meta-analysis. Obstet Gynecol. 2023;141:59\u201368.","journal-title":"Obstet Gynecol"},{"key":"2550_CR24","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/S0140-6736(22)00323-3","volume":"399","author":"EJ Crosbie","year":"2022","unstructured":"Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399:1412\u201328.","journal-title":"Lancet"},{"key":"2550_CR25","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5812\/iranjradiol.5276","volume":"9","author":"F Zamani","year":"2012","unstructured":"Zamani F, Goodarzi S, Hallaji F, Zamiri A, Deilami T, Malek M, et al. Diagnostic Value of Pelvic MRI for Assessment of the depth of Myometrial Invasion and Cervical involvement in Endometrial Cancer: comparison of New Versus Old FIGO staging. Iran J Radiol. 2012;9:202\u20138.","journal-title":"Iran J Radiol"},{"key":"2550_CR26","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3389\/fonc.2020.01236","volume":"10","author":"Y Wang","year":"2020","unstructured":"Wang Y, Li B, Ren F, Song Z, Ouyang L, Liu K. Survival after minimally invasive vs. Open Radical Hysterectomy for Cervical Cancer: a Meta-analysis. Front Oncol. 2020;10:1236.","journal-title":"Front Oncol"},{"key":"2550_CR27","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.3390\/curroncol29020093","volume":"29","author":"O Touhami","year":"2022","unstructured":"Touhami O, Plante M. Minimally invasive surgery for cervical Cancer in light of the LACC Trial: what have we learned? Curr Oncol. 2022;29:1093\u2013106.","journal-title":"Curr Oncol"},{"key":"2550_CR28","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.3390\/curroncol29040185","volume":"29","author":"T Tanaka","year":"2022","unstructured":"Tanaka T, Ueda S, Miyamoto S, Hashida S, Terada S, Konishi H, et al. Comparison of prognosis between minimally invasive and abdominal radical hysterectomy for patients with early-stage cervical Cancer. Curr Oncol. 2022;29:2272\u201383.","journal-title":"Curr Oncol"},{"key":"2550_CR29","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1136\/ijgc-2020-001506","volume":"30","author":"L Chiva","year":"2020","unstructured":"Chiva L, Zanagnolo V, Querleu D, Martin-Calvo N, Ar\u00e9valo-Serrano J, C\u0103p\u00eelna ME, et al. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer. Int J Gynecol Cancer. 2020;30:1269\u201377.","journal-title":"Int J Gynecol Cancer"},{"key":"2550_CR30","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.3802\/jgo.2019.30.e71","volume":"30","author":"H Kanao","year":"2019","unstructured":"Kanao H, Matsuo K, Aoki Y, Tanigawa T, Nomura H, Okamoto S, et al. Feasibility and outcome of total laparoscopic radical hysterectomy with no-look no-touch technique for FIGO IB1 cervical cancer. J Gynecol Oncol. 2019;30:e71.","journal-title":"J Gynecol Oncol"},{"key":"2550_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ygyno.2017.07.119","volume":"147","author":"Y Qian","year":"2017","unstructured":"Qian Y, Pollom EL, Nwachukwu C, Seiger K, von Eyben R, Folkins AK, et al. Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma. Gynecol Oncol. 2017;147:24\u20139.","journal-title":"Gynecol Oncol"},{"key":"2550_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/PGP.0000000000000805","volume":"41","author":"EEM Peters","year":"2022","unstructured":"Peters EEM, L\u00e9on-Castillo A, Hogdall E, Boennelycke M, Smit V, Hogdall C, et al. Substantial Lymphovascular Space Invasion is an adverse prognostic factor in high-risk endometrial Cancer. Int J Gynecol Pathol. 2022;41:227\u201334.","journal-title":"Int J Gynecol Pathol"},{"key":"2550_CR33","doi-asserted-by":"crossref","unstructured":"Jaishankar S, Pifer PM, Bhargava R, Keller A, Musunuru HB, Patel AK et al. Is substantial Lymphovascular Space Invasion Prognostic for clinical outcomes in type II endometrial Cancer? Clin Oncol (R Coll Radiol). 2022; 34:452\u20138.","DOI":"10.1016\/j.clon.2022.02.018"},{"key":"2550_CR34","doi-asserted-by":"publisher","first-page":"e5921","DOI":"10.1016\/j.ajog.2017.01.027","volume":"216","author":"S Uccella","year":"2017","unstructured":"Uccella S, Bonzini M, Malzoni M, Fanfani F, Palomba S, Aletti G, et al. The effect of a uterine manipulator on the recurrence and mortality of endometrial cancer: a multi-centric study by the Italian Society of Gynecological Endoscopy. Am J Obstet Gynecol. 2017;216:e5921\u201311.","journal-title":"Am J Obstet Gynecol"},{"key":"2550_CR35","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.21037\/tcr-20-2094","volume":"9","author":"VA Capozzi","year":"2020","unstructured":"Capozzi VA, Rosati A, Uccella S, Riemma G, Tarascio M, Torella M, et al. Role of uterine manipulator during laparoscopic endometrial cancer treatment. Transl Cancer Res. 2020;9:7759\u201366.","journal-title":"Transl Cancer Res"},{"key":"2550_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/GMIT.GMIT_65_20","volume":"10","author":"A Yavuzcan","year":"2021","unstructured":"Yavuzcan A, Alt\u0131nta\u015f R, Y\u0131ld\u0131z G, Ba\u015fbu\u011f A, Ba\u015ftan M, \u00c7a\u011flar M. Does Uterine Manipulator Type Affect Surgical outcomes of laparoscopic hysterectomy? Gynecol Minim Invasive Ther. 2021;10:19\u201324.","journal-title":"Gynecol Minim Invasive Ther"},{"key":"2550_CR37","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.jmig.2021.01.013","volume":"28","author":"Y Liu","year":"2021","unstructured":"Liu Y, Huang S, Ming X, Jing H, Li Z. Surgical Approach and Use of Uterine Manipulator are not Associated with LVSI in surgery for early-stage Cervical Cancer. J Minim Invasive Gynecol. 2021;28:1573\u20138.","journal-title":"J Minim Invasive Gynecol"},{"key":"2550_CR38","doi-asserted-by":"publisher","first-page":"151503","DOI":"10.1016\/j.anndiagpath.2020.151503","volume":"46","author":"S Stolnicu","year":"2020","unstructured":"Stolnicu S, Terinte C, Ioanid N, Silva E. Presence of tumor cells in the vagina during surgical treatment could be the source of vaginal recurrence in patients with endometrial carcinoma - A pilot prospective study. Ann Diagn Pathol. 2020;46:151503.","journal-title":"Ann Diagn Pathol"},{"key":"2550_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12957-020-01876-x","volume":"18","author":"SA Barquet-Mu\u00f1oz","year":"2020","unstructured":"Barquet-Mu\u00f1oz SA, Cant\u00fa-de-Le\u00f3n D, Bandala-Jacques A, Gonz\u00e1lez-Enciso A, Isla-Ortiz D, Prada D, et al. What is the impact of radical hysterectomy on endometrial cancer with cervical involvement? World J Surg Oncol. 2020;18:101.","journal-title":"World J Surg Oncol"},{"key":"2550_CR40","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.7150\/ijms.60718","volume":"18","author":"SI Kim","year":"2021","unstructured":"Kim SI, Yoon JH, Lee SJ, Song MJ, Kim JH, Lee HN, et al. Prediction of lymphovascular space invasion in patients with endometrial cancer. Int J Med Sci. 2021;18:2828\u201334.","journal-title":"Int J Med Sci"},{"key":"2550_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/PGP.0000000000000246","volume":"35","author":"EL Pollom","year":"2016","unstructured":"Pollom EL, Conklin CM, von Eyben R, Folkins AK, Kidd EA. Nomogram to predict risk of Lymph Node metastases in patients with endometrioid endometrial Cancer. Int J Gynecol Pathol. 2016;35:395\u2013401.","journal-title":"Int J Gynecol Pathol"},{"key":"2550_CR42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/ijgc-2019-000824","volume":"30","author":"G Bogani","year":"2020","unstructured":"Bogani G, Tibiletti MG, Ricci MT, Carnevali I, Liberale V, Paolini B, et al. Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomes. Int J Gynecol Cancer. 2020;30:56\u201361.","journal-title":"Int J Gynecol Cancer"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-024-02550-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-024-02550-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-024-02550-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T18:04:59Z","timestamp":1725991499000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcsurg.biomedcentral.com\/articles\/10.1186\/s12893-024-02550-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,10]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2550"],"URL":"https:\/\/doi.org\/10.1186\/s12893-024-02550-9","relation":{},"ISSN":["1471-2482"],"issn-type":[{"type":"electronic","value":"1471-2482"}],"subject":[],"published":{"date-parts":[[2024,9,10]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of Ethics Committee of the Cancer Hospital Affiliated with Fujian Medical University (NO.K2022-064-01). The retrospective nature of the study led to a waiver of participant consent by the institutional review board of Ethics Committee of the Cancer Hospital Affiliated with Fujian Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"254"}}